Zydus Lifesciences gets EIR from USFDA for Pharmez facility

Published On 2023-07-03 06:14 GMT   |   Update On 2023-07-03 06:17 GMT
Advertisement

Ahmedabad: Zydus Lifesciences has recently announced thatthe Company has received the Establishment Inspection Report (EIR) from the United States Foos and Drug Administration (USFDA) for the inspection conducted at its manufacturing facility located at Pharmez, Ahmedabad,from March 20 to 24, 2023.

The inspection has been classified as Voluntary Action Indicated (VAI). The EIR report indicates that the inspection is closed.

Advertisement

Medical Dialogues team had earlier reported that the USFDA had concluded an inspection with three observations at the Company's said manufacturing facility.

Read also: USFDA issues 3 observations for Zydus Lifesciences Ahmedabad facility

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian Pharmaceutical company headquartered in Ahmedabad. The Company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals. It is primarily engaged in the manufacture of generic drugs.

Read also: Zydus Lifesciences bags USFDA tentative nod for breast cancer drug Palbociclib




Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News